Saturday, 27 February 2021
- Welcome Guest
- Media Kit INR
- Media Kit USD
- Subscribe
- Newsletter
- Login/Sign Up
LIVE
Video
Kavin Kumar Kandasamy, Founder and Chief Executive Officer, MY, Coimbatore
TRENDING NEWS
- POLICY & REGULATORY
-
Govt allocates PLI scheme of Rs 6,940 Cr for bulk drugs & Rs 3,420 Cr for medical devices
Centre approves PLI scheme for pharmaceuticals for FY 2020-21 to 2028-29
India comes out first to identify need for action for NAFLD
- FINANCE
-
Palladium designs India’s first Social Impact Bond in healthcare sector
Advent International acquires majority stake in ZCL Chemicals
FDI India provides foreign credit options to pharma sector
- COMPANY
-
Sun Pharma launches website for long-term care division in US
Blue Star launches free diagnostic programme for underprivileged women
Pregna introduces economical solution to post-partum haemorrhage
- WORLD
-
Egypt approves Sputnik V COVID-19 vaccine
Mexico receives first batch of Sputnik V vaccine
WHO announces no-fault compensation programme for COVID-19 vaccines
-
Science | 26 February 2021 | News
RRI develops technique for early diagnosis of cancer, Alzheimer’s, Parkinson’s
Scientists have developed a new technique to measure DNA modifications that can have applications in early dia...Read more
-
Opinion | 16 February 2021 | News
Applying cushion for India against future supply shocks
As the world grapples with a never before seen viral pandemic, the pharmaceutical sector has been at the foref...Read more
-
Analysis | 22 December 2020 | Views
Virtualisation could truly democratize healthcare in India
Ever since the onset of the current times we are living in, healthcare & pharma sectors have been busy to ...Read more
-
Start-ups | 23 February 2021 | News
ekincare builds wellness-based products with insurance firms
ekincare has announced capabilities to partner with health-insurance companies through white-labeled platforms...Read more
-
Supplier | 25 February 2021 | News
Waters partners with TetraScience to provide unparalleled insights into chromatography data
Waters Corporation has entered a reseller agreement with TetraScience, a cloud technology innovator power...Read more
-
People | 23 February 2021 | News
Mom’s Belief onboards Dr Mohan Chellappa as member of advisory board
Mom’s Belief, India’s premier mental healthcare platform for a child with special needs, has onboa...Read more
-
Academics | 24 February 2021 | News
Tata STRIVE, Wipro GE Healthcare to skill youth for jobs in healthcare sector
Tata STRIVE and Wipro GE Healthcare have entered into a partnership to skill youth for jobs in the healthcare ...Read more
-
Text blogs | 18 January 2021 | Views
Impact of sensitive and reliable kits for covid-19 testing at a scale.
In May 2020, 15 of the 25 samples tested by Government Villupuram Medical College, Villupuram, Tamil Nadu, tur...Read more
Videos
Inside Magazine
INDIAN BIOPHARMA HITS RS 25,000 CRORE RIDING 15% GROWTH WAVE
The Indian Biopharma Industry, with over 300 companies, is growing at the rate of 15 per cent, which is 3 per cent more than the previous year’s 12 per cent. This growth was largely driven by over 20 per cent growth rate recorded by 8 of the top 20 companies in the biopharma space. As a result, the Indian Biopharma Industry has crossed the Rs 25,000 crore mark for the year 2019-20 over the previous year’s figure of Rs 22,124 crore. In 2017-18 the industry recorded a revenue of Rs 18,290 crore. The Indian Biopharma industry, comprising hormones, insulin, blood products and vaccines recorded a sales revenue of Rs 25,442 crore for the year 2019-20.
For Feedback, please email us at : communications@mmactiv.com
-- BioSpectrum Infomercial
